“Asia Vaccines market set to grow to $11.7bn by 2024” says new Visiongain report

28 October 2019
Pharma

Visiongain has launched a new pharma report Asia Vaccines Market Forecast to 2029: Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Influenza, Hepatitis, Polio, Meningococcal, DTP, Rotavirus, MMR, HPV.

Globally, Asia is identified as a lucrative market for the vaccine development companies to establish and expand their presence in economies such as Japan, China and India. In addition, introduction of new technologies for development of innovative vaccines and rising government support also drive the market during the forecast period.

The lead analyst of the report commented "The vaccines market has witnessed a strong growth in the past few years, as the demand for vaccines is increasing in many Asian countries. Increased awareness for vaccination is one of the prominent factors driving the emerging market growth. This has led to intensified vaccination programmes for adolescents and growing geriatric population.

Japan accounted for the largest share of the vaccines market in Asia. Growth in the Japanese Vaccine market is driven by two main factors. First is the easing of Japan’s strict barriers to entry for foreign companies. Secondly, growth will be further driven by the population of elderly in Japan."

Leading companies featured in the report include Astellas, AstraZeneca
CSL, Ltd., Emergent BioSolutions, Inc., GlaxoSmithKline, Johnson & Johnson, Merck, Mitsubishi Tanabe Pharma Corporation, Pfizer, Sanofi, Serum Institute of India Pvt. Ltd., Sun Pharmaceuticals Industries, Ltd., Takeda and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

Read

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

Read

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

Read

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever